Association study in Romanians confirms IL23A gene haplotype block rs2066808/rs11171806 as conferring risk to psoriatic arthritis

Cytokine

Volumn 63, Issue 1, 2013, Pages 67-73

  Popa, Olivia Mihaela ^a,b   Kriegova, Eva ^b   Popa, Luis ^c   Schneiderova, Petra ^b   Dutescu, Monica Irina ^d   Bojinca, Mihai ^a   Bara, Constantin ^a   Petrek, Martin ^b  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b PALACKÝ UNIVERSITY   (Czech Republic)

^c Grigore Antipa National Museum of Natural History   (Romania)

^d National Institute of Hematology and Blood Transfusion   (Romania)

Author keywords

Genetic association; IL12B; IL23A; IL23R; Psoriatic arthritis

Indexed keywords

INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 23P19;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ETHNICITY; FEMALE; GENE; GENE FREQUENCY; GENE MAPPING; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; IL12A GENE; IL12B GENE; IL12RB1 GENE; IL23A GENE; IL23R GENE; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PSORIATIC ARTHRITIS; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, PSORIATIC; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTERLEUKIN-12 SUBUNIT P35; INTERLEUKIN-23 SUBUNIT P19; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN; RISK FACTORS; ROMANIA; YOUNG ADULT;

EID: 84878916456     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.04.013     Document Type: Article

References (36)

1. Gottlieb A., Korman N.J., Gordon K.B., Feldman S.R., Lebwohl M., Koo J.Y., et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol 2008, 58(5):851-864.
2. Maeda S., Hayami Y., Naniwa T., Ueda R. The Th17/IL-23 axis and natural immunity in psoriatic arthritis. Int J Rheumatol 2012, 2012:539683.
3. Bowes J., Orozco G., Flynn E., Ho P., Brier R., Marzo-Ortega H., et al. Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis. Ann Rheum Dis 2011, 70(9):1641-1644.
4. Jadon D., Tillett W., Wallis D., Cavill C., Bowes J., Waldron N., et al. Exploring ankylosing spondylitis-associated ERAP1, IL23R and IL12B gene polymorphisms in subphenotypes of psoriatic arthritis. Rheumatology (Oxford) 2013, 52(2):261-266.
5. Piskin G., Sylva-Steenland R.M., Bos J.D., Teunissen M.B. In vitro and in situ expression of IL23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. J Immunol 2006, 176(3):1908-1915.
6. Zaghi D., Krueger G.G., Callis Duffin K. Ustekinumab: a review in the treatment of plaque psoriasis and psoriatic arthritis. J Drugs Dermatol 2012, 11(2):160-167.
7. Oppmann B., Lesley R., Blom B., Timans J.C., Xu Y., Hunte B., et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000, 13:715-725.
8. Tang C., Chen Shu, Qian Hai, Huang Wenlong Interleukin-23: as a drug target for autoimmune inflammatory diseases. Immunology 2011, 135:112-124.
9. Di Cesare A., Di Meglio P., Nestle F.O. The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 2009, 129(6):1339-1350.
10. Duan Z., Pan F., Zeng Z., Zhang T., Wang S., Li G., et al. Interleukin-23 receptor genetic polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis. Rheumatol. Int. 2012, 32(5):1209-1214.
11. McGovern D., Powrie F. The IL23 axis plays a key role in the pathogenesis of IBD. Gut 2007, 56(10):1333-1336.
12. Duffin K.C., Krueger G.G. Genetic variations in cytokines and cytokine receptors associated with psoriasis found by genome-wide association. J Invest Dermatol 2009, 129(4):827-833.
13. Rahman P., Inman R.D., Maksymowych W.P., Reeve J.P., Peddle L., Gladman D.D. Association of interleukin 23 receptor variants with psoriatic arthritis. J Rheumatol 2009, 36(1):137-140.
14. Filer C., Ho P., Smith R.L., Griffiths C., Young H.S., Worthington J., et al. Investigation of association of the IL12B and IL23R genes with psoriatic arthritis. Arthritis Rheum 2008, 58(12):3705-3709.
15. Hüffmeier U., Lascorz J., Böhm B., Lohmann J., Wendler J., Mössner R., et al. Genetic variants of the IL-23R pathway: association with psoriatic arthritis and psoriasis vulgaris, but no specific risk factor for arthritis. J Invest Dermatol 2009, 129(2):355-358.
16. Taylor W., Gladman D., Helliwell P., Marchesoni A., Mease P., Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006, 54:2665-2673.
17. Rahman P., Inman R.D., Gladman D.D., Reeve J.P., Peddle L., Maksymowych W.P. Association of interleukin-23 receptor variants with ankylosing spondylitis. Arthritis Rheum 2008, 58(4):1020-1025.
18. Tindall E.A., Hayes V.M. Comprehensive sequence analysis of the human IL23A gene defines new variation content and high rate of evolutionary conservation. DNA Res 2010, 17(2):117-122.
19. Stacey G, Ziaugra L, Tabbaa D. SNP genotyping using the sequenom MassARRAY iPLEX platform. Curr Protoc Hum Genet 2009;60:2.12.1-2.12.18.
20. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007, 81:559-575.
21. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., et al. The structure of haplotype blocks in the human genome. Science 2002, 296(5576):2225-2229.
22. Johnson R.C., Nelson G.W., Troyer J.L., Lautenberger J.A., Kessing Bailey D., Winkler Chery A., et al. Accounting for multiple comparisons in a genome-wide association study (GWAS). BMC Genomics 2010, 11:724-730.
23. Zaykin D.V., Meng Z., Ehm M.G. Contrasting linkage-disequilibrium patterns between cases and controls as a novel association-mapping method. Am J Hum Genet 2006, 78(5):737-746.
24. Quanto Package. Version 1.2.3. (accessed on 9.02.13). http://hydra.usc.edu/gxe/.
25. McGovern D.P., Rotter J.I., Mei L., Haritunians T., Landers C., Derkowski C., et al. Genetic epistasis of IL23/IL17 pathway genes in Crohn's disease. Inflamm Bowel Dis 2009, 15(6):883-889.
26. Chang Y.T., Chou C.T., Yu C.W., Lin M.W., Shiao Y.M., Chen C.C., et al. Cytokine gene polymorphisms in Chinese patients with psoriasis. Br J Dermatol 2007, 156(5):899-905.
27. Gonzalez-Galarza F.F., Christmas S., Middleton D., Jones A.R. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res 2011, 39:D913-919.
28. Liu Y., Helms C., Liao W., Zaba L.C., Duan S., Gardner J., et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet 2008, 4(3):e1000041.
29. Hüffmeier U., Uebe S., Ekici A.B., Bowes J., Giardina E., Korendowych E., et al. Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. Nat Genet 2010, 42(11):996-999.
30. Szodoray P., Alex P., Chappell-Woodward C.M., Madland T.M., Knowlton N., Dozmorov I., et al. Circulating cytokines in Norwegian patients with psoriatic arthritis determined by a multiplex cytokine array system. Rheumatology 2007, 46:417-425.
31. Nair R.P., Duffin K.C., Helms C., Ding J., Stuart P.E., Goldgar D., et al. Collaborative association study of psoriasis genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 2009, 41(2):199-204.
32. Lee E., Trepicchio W.L., Oestreicher J.L., Pittman D., Wang F., Chamian F., et al. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med 2004, 199(1):125-130.
33. Taylor K.D., Targan S.R., Mei L., Ippoliti A.F., McGovern D., Mengesha E., et al. IL23R haplotypes provide a large population attributable risk for Crohn's disease. Inflamm Bowel Dis 2008, 14(9):1185-1191.
34. Catanoso M.G., Boiardi L., Macchioni P., Garagnani P., Sazzini M., De Fanti S., et al. IL-23A, IL-23R, IL-17A and IL-17R polymorphisms in different psoriatic arthritis clinical manifestations in the northern Italian population. Rheumatol Int 2013, 33(5):1165-1176.
35. Karaderi T., Harvey D., Farrar C., Appleton L.H., Stone M.A., Sturrock R.D., et al. Association between the interleukin 23 receptor and ankylosing spondylitis is confirmed by a new UK case-control study and meta-analysis of published series. Rheumatology (Oxford) 2009, 48(4):386-389.
36. Sáfrány E., Pazár B., Csöngei V., Járomi L., Polgár N., Sipeky C., et al. Variants of the IL23R gene are associated with ankylosing spondylitis but not with Sjögren syndrome in Hungarian population samples. Scand J Immunol 2009, 70(1):68-74.